Moreover, unphosphorylated signal transducer and activator of transcription 1 (STAT1) may sustain the expression of interferon-stimulated genes (ISGs) that contribute to resistance to DNA damage, which may contribute to diminished response to cancer therapy[9]. This evidence concerns the gene STAT1 and cancer.